Re-Primed for a big move up....18 Jul 2018 08:17
Nice article.
RNS today.
Manchester, UK - 18 July 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life sciences company focused on skin health, announces that it has received provisional ethics approval for its human study scheduled to start later this year.